Our CEO Nakada answered an interview in an article "Special Interview" in the July 2nd issue of "Medical Journal", Japan Medical Journal.

The government cites the promotion of medical DX in the "Honebuto Policy 2022".
In the interview, our company is introduced as promoting DX in medical care by commercializing Smart119, an emergency medical information system, and "respon:sum", a medical business continuity supporting system.

This article is also available on "Web Medical Journal".
https://www.jmedj.co.jp/journal/paper/detail.php?id=19905